{"transactions":[{"id":838487,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":100500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838486,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":309000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":309000,"derivative":{"exercise_price":8.62,"expiration_date":"2036-03-13","underlying":"Class A Common Stock","underlying_shares":309000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838485,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":278000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":278000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":278000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838484,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T17:00:22.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":153000,"derivative":{"exercise_price":9.61,"expiration_date":"2035-03-14","underlying":"Class A Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838483,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T17:00:22.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":134000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":134000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":134000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838482,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":14553,"price":8.62,"value":125446.86,"ownership":{"direct":true},"balance_after":135944,"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838481,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":150497,"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":940170,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-13T17:30:00.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":false,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":187500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0002005474-26-000002","document":"wk-form4_1768343397.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000002/wk-form4_1768343397.xml","form_type":"4"}},{"id":940169,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-01-13T17:30:00.000Z","date":"2026-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":41717,"price":8.03,"value":334987.51,"ownership":{"direct":true},"balance_after":116997,"source":{"system":"sec-edgar","filing":"0002005474-26-000002","document":"wk-form4_1768343397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000002/wk-form4_1768343397.xml","form_type":"4"}},{"id":940168,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-01-13T17:30:00.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158714,"source":{"system":"sec-edgar","filing":"0002005474-26-000002","document":"wk-form4_1768343397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000002/wk-form4_1768343397.xml","form_type":"4"}},{"id":1303663,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-01-14T18:59:50.000Z","date":"2025-01-13","kind":"sale","planned":true,"acquired":false,"shares":28786,"price":9.1,"value":261952.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on January 10, 2025 pursuant to a standing 10b5-1 instruction adopted on January 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.935 to $9.22, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64964,"source":{"system":"sec-edgar","filing":"0001578563-25-000023","document":"wk-form4_1736899184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000157856325000023/wk-form4_1736899184.xml","form_type":"4"}},{"id":1304449,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-13T17:24:32.000Z","date":"2025-01-10","kind":"exercise","planned":false,"acquired":false,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":281250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001578563-25-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000157856325000015/primary_doc.xml","form_type":"4"}},{"id":1304448,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-01-13T17:24:32.000Z","date":"2025-01-10","kind":"exercise","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":93750,"source":{"system":"sec-edgar","filing":"0001578563-25-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000157856325000015/primary_doc.xml","form_type":"4"}},{"id":1680169,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-12T16:52:30.000Z","date":"2024-01-11","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":850000,"derivative":{"exercise_price":4.89,"expiration_date":"2034-01-11","underlying":"Class A Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001578563-24-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000157856324000014/primary_doc.xml","form_type":"4"}},{"id":1680168,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock  Units","published_at":"2024-01-12T16:52:30.000Z","date":"2024-01-11","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":375000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001578563-24-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000157856324000014/primary_doc.xml","form_type":"4"}}]}